April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Triamcinolone as an Adjuvant to Reduce Post-operative Epiretinal Membrane Peel Edema- A Pilot Study
Author Affiliations & Notes
  • Rishi P. Singh
    Ophthalmology i-32, Cole Eye Institute, Cleveland, Ohio
  • Anirudh Paspulati
    Case Western Reserve University, Cleveland, Ohio
  • Sofia Theodoropoulou
    Ophthalmology, MEEI, Harvard Medical School, Boston, Massachusetts
  • Footnotes
    Commercial Relationships  Rishi P. Singh, None; Anirudh Paspulati, None; Sofia Theodoropoulou, None
  • Footnotes
    Support  Research to Prevent Blindness Foundation Unrestricted Grant
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 4494. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Rishi P. Singh, Anirudh Paspulati, Sofia Theodoropoulou; Triamcinolone as an Adjuvant to Reduce Post-operative Epiretinal Membrane Peel Edema- A Pilot Study. Invest. Ophthalmol. Vis. Sci. 2011;52(14):4494.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate the clinical outcome and complications of post-operative intravitreal injections of triamcinolone acetonide (TA) in patients undergoing pars plana vitrectomy with peeling for the treatment of idiopathic epiretinal membrane.

Methods: : This retrospective comparative study included 22 patients (22 eyes) who underwent pars plana vitrectomy with membrane peeling for the treatment of idiopathic epiretinal membrane. 15 eyes (15 patients) received an intravitreal injection of 4mg (0.1 cc) of triamcinolone acetonide at the end of surgery, and no injection was done for 7 eyes (7 patients). Main outcome measures were visual acuity (VA) and intraocular pressure (IOP). Minimum follow-up was 3 months.

Results: : Twenty-two eyes of 22 patients were included in the study. The follow-up ranged from 3 to 12 months. Visual acuity three months after operation was improved in both group of patients receiving intravitreal injection of TA and control group (p0.05).

Conclusions: : The present pilot study suggests that postoperative intravitreal injection of triamcinolone acetonide does not lead to better visual outcomes in patients undergoing pars plana vitrectomy for the treatment of idiopathic epiretinal membranes.

Keywords: vitreoretinal surgery • edema • retina 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×